Panobinostat resistance of cutaneous T-cell lymphoma (CTCL) cells is related to high Bcl2 family expression; Bcl-2 inhibitor sensitized CTCL cells to panobinostat [43]. Here, BCL2 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.